M.S. in Biotechnology Management and Entrepreneurship Degree Explore NYC's Top Biotech Master's Program Request More Info Apply Now Attend an Info Session Contact Us Artificial Intelligence Biotechnology Computer Science Cybersecurity Data Analytics and Visualization Digital Marketing and Media Mathematics Occupational Therapy Physician Assistant Physics Speech-Language Pathology Bring life-saving science to market — from AI-accelerated discovery through development and regulatory approval. Earn your master's in biotech at a U.S. News Top 100 University in the heart of New York City. Total tuition: $19K (all U.S. students) or $35K (international). M.S. in Biotechnology Management & Entrepreneurship12 Courses I On-Campus in Midtown NYC I Daytime or Evening Classes I Full-Time (21 Months) or Part-Time Biotechnology and medical technology organizations now operate in an environment where artificial intelligence accelerates target discovery, reshapes clinical trial design, and informs pricing and portfolio decisions. At the same time, companies face global competition and heightened scrutiny of data governance and AI deployment. The Katz School's master's in biotech prepares you to integrate emerging technologies with regulatory and commercial strategy, make decisions under uncertainty, and lead across the full product lifecycle in a field defined by scientific rigor and technological acceleration.This interdisciplinary program prepares you to work across the full biotech value chain, from drug discovery and clinical trials through regulatory approval and commercialization. You'll develop the scientific fluency and strategic judgment to evaluate translational risk, structure commercialization pathways, and align intellectual property and reimbursement strategy with data-driven R&D. Through applied projects and a capstone experience, you'll build investor-ready strategies that translate innovation into regulated, scalable products. Program Highlights Hands-on expertise: Design and execute AI-integrated product and go-to-market strategies across discovery, clinical development, regulatory approval, and commercialization. 93% graduate employment: Alumni land roles in business development, product and project management, clinical trials, life science consulting, and commercialization at companies like Merck, Kantar Health, BioMarin, New York Stem Cell Foundation, Lucerna, and SFA Therapeutics. Median starting salary: $85,000. Flexible scheduling: Full-time or part-time, with daytime and evening classes on campus in Midtown NYC. Top-ranked university in the heart of NYC: #1 Best Value and Top 100 University by U.S. News; #63 in the U.S. by QS World Total tuition: $19K (all U.S. students) or $35K (international) after the STEM Fellows Scholarship, plus the opportunity to present research at the Katz School's Symposium on Science, Technology and Health. STEM-OPT: International students may be eligible for up to 3 years of Optional Practical Training. Full Program Breakdown M.S. in Biotechnology Management & Entrepreneurship12 Courses I On-Campus in Midtown NYC I Daytime or Evening Classes I Full-Time (21 Months) or Part-Time Biotechnology and medical technology organizations now operate in an environment where artificial intelligence accelerates target discovery, reshapes clinical trial design, and informs pricing and portfolio decisions. At the same time, companies face global competition and heightened scrutiny of data governance and AI deployment. The Katz School's master's in biotech prepares you to integrate emerging technologies with regulatory and commercial strategy, make decisions under uncertainty, and lead across the full product lifecycle in a field defined by scientific rigor and technological acceleration.This interdisciplinary program prepares you to work across the full biotech value chain, from drug discovery and clinical trials through regulatory approval and commercialization. You'll develop the scientific fluency and strategic judgment to evaluate translational risk, structure commercialization pathways, and align intellectual property and reimbursement strategy with data-driven R&D. Through applied projects and a capstone experience, you'll build investor-ready strategies that translate innovation into regulated, scalable products. Program Highlights Hands-on expertise: Design and execute AI-integrated product and go-to-market strategies across discovery, clinical development, regulatory approval, and commercialization. 93% graduate employment: Alumni land roles in business development, product and project management, clinical trials, life science consulting, and commercialization at companies like Merck, Kantar Health, BioMarin, New York Stem Cell Foundation, Lucerna, and SFA Therapeutics. Median starting salary: $85,000. Flexible scheduling: Full-time or part-time, with daytime and evening classes on campus in Midtown NYC. Top-ranked university in the heart of NYC: #1 Best Value and Top 100 University by U.S. News; #63 in the U.S. by QS World Total tuition: $19K (all U.S. students) or $35K (international) after the STEM Fellows Scholarship, plus the opportunity to present research at the Katz School's Symposium on Science, Technology and Health. STEM-OPT: International students may be eligible for up to 3 years of Optional Practical Training. Swipe to learn more! M.S. in Biotechnology Management & Entrepreneurship12 Courses I On-Campus in Midtown NYC I Daytime or Evening Classes I Full-Time (21 Months) or Part-Time Biotechnology and medical technology organizations now operate in an environment where artificial intelligence accelerates target discovery, reshapes clinical trial design, and informs pricing and portfolio decisions. At the same time, companies face global competition and heightened scrutiny of data governance and AI deployment. The Katz School's master's in biotech prepares you to integrate emerging technologies with regulatory and commercial strategy, make decisions under uncertainty, and lead across the full product lifecycle in a field defined by scientific rigor and technological acceleration.This interdisciplinary program prepares you to work across the full biotech value chain, from drug discovery and clinical trials through regulatory approval and commercialization. You'll develop the scientific fluency and strategic judgment to evaluate translational risk, structure commercialization pathways, and align intellectual property and reimbursement strategy with data-driven R&D. Through applied projects and a capstone experience, you'll build investor-ready strategies that translate innovation into regulated, scalable products. Hands-on expertise: Design and execute AI-integrated product and go-to-market strategies across discovery, clinical development, regulatory approval, and commercialization. 93% graduate employment: Alumni land roles in business development, product and project management, clinical trials, life science consulting, and commercialization at companies like Merck, Kantar Health, BioMarin, New York Stem Cell Foundation, Lucerna, and SFA Therapeutics. Median starting salary: $85,000. Flexible scheduling: Full-time or part-time, with daytime and evening classes on campus in Midtown NYC. Top-ranked university in the heart of NYC: #1 Best Value and Top 100 University by U.S. News; #63 in the U.S. by QS World Total tuition: $19K (all U.S. students) or $35K (international) after the STEM Fellows Scholarship, plus the opportunity to present research at the Katz School's Symposium on Science, Technology and Health. STEM-OPT: International students may be eligible for up to 3 years of Optional Practical Training. View Curiculum Apply Now Program Links CurriculumFacultyResearchStudent Life and ServicesAdmissionsSTEM Fellows ScholarshipMission and Goals Admissions & Financial Aid Contact Us Admissions RequirementsBachelor’s degree – with typical majors in biology, pre-med or any STEM discipline, as well as business, finance, marketing, public health, and other clinical majors.Prerequisites – some biology or life science coursework or professional experience in business, finance, law or marketing. If no biology background, a life science course is available in the first semester.Application Information Visit Graduate Admissions for up-to-date application requirements and deadlines. Questions? Schedule an appointment with an admissions director if you have questions about your qualifications, financial aid opportunities and financing your graduate degree. We can do a preliminary transcript review and discuss your admissions and financing options with the Katz School. B.A./M.S. Pathways OptionThrough the B.A./M.S. program, undergraduates from Yeshiva College and Stern College for Women can take up to nine graduate credits that count toward both the bachelor’s and master's degrees. After completing the bachelor’s, students can finish the graduate degree in just one more year. Learn more at yu.edu/pathways.Tuition, Financial Aid and Scholarships The Office of Student Finance maintains current tuition and fees for all graduate programs. All applicants are automatically considered for the STEM Fellows program. You do not need to submit any additional information. Graduate Admissionskatzgrad@yu.edu646-592-4753General Inquirieskatz@yu.eduJoin our CommunityLinkedInInstagramYouTubeFacebookFlickr Admissions & Financial Aid Admissions RequirementsBachelor’s degree – with typical majors in biology, pre-med or any STEM discipline, as well as business, finance, marketing, public health, and other clinical majors.Prerequisites – some biology or life science coursework or professional experience in business, finance, law or marketing. If no biology background, a life science course is available in the first semester.Application Information Visit Graduate Admissions for up-to-date application requirements and deadlines. Questions? Schedule an appointment with an admissions director if you have questions about your qualifications, financial aid opportunities and financing your graduate degree. We can do a preliminary transcript review and discuss your admissions and financing options with the Katz School. B.A./M.S. Pathways OptionThrough the B.A./M.S. program, undergraduates from Yeshiva College and Stern College for Women can take up to nine graduate credits that count toward both the bachelor’s and master's degrees. After completing the bachelor’s, students can finish the graduate degree in just one more year. Learn more at yu.edu/pathways.Tuition, Financial Aid and Scholarships The Office of Student Finance maintains current tuition and fees for all graduate programs. All applicants are automatically considered for the STEM Fellows program. You do not need to submit any additional information. Contact Us Graduate Admissionskatzgrad@yu.edu646-592-4753General Inquirieskatz@yu.eduJoin our CommunityLinkedInInstagramYouTubeFacebookFlickr Meet the Faculty Dr. Oliveira is Advancing Medical Technologies with the Power of Marine Bioluminescent EnzymesFrom deep-sea bioluminescence to antifreeze proteins, Dr. Anderson Garbuglio de Oliveira's trailblazing research is set to advance disease detection, allowing for earlier diagnoses and improved patient outcomes. Dr. Jochen Raimann's Cutting-Edge Epidemiological Research in DialysisIndustry professor of biotechnology, Dr. Raimann, has been a full-time scientist at the Renal Research Institute (RRI) since 2007. As RRI's director of data analytics, he conducts epidemiological research in dialysis, oversees research database management and national and international data transfers. RECENT RESEARCH Meet Your Classmates Christine Chery '25 on the Commercialization Potential for Novel Cancer Treatment JunAPDeveloped by Sapience Therapeutics, Inc., JunAP is a cutting-edge peptide antagonist that inhibits the AP-1 transcription factor complex, a key player in oncogenesis and immune suppression. Natania Birnbaum '24 on Duckweed's Potential for Sustainable, Space-Based Food ProductionDuckweed is a small, fast-growing, nutritionally dense aquatic plant that’s being investigated for human consumption and for growing in outer space. Under the guidance of Professor Robert Friedman and Industry Mentor John McShane, MS '21, Natania conducted a comprehensive survey of duckweed biology, genetics, and cultivation methods and charted the current economic landscape and future projections for the duckweed market. Read More Program News International Students Spark Cultural Dialogue Read about the students International Students Spark Cultural Dialogue Three Katz School international students, including one from the biotechnology master's program, volunteered to share their experiences from their country of origin with New York City public school children as part of One to World, a New York City–based global leadership and cultural exchange program.Read the story in the Katz School blog. He Used AI to Explore Vaccine Supply Chains Read Yeukai Magara's report He Used AI to Explore Vaccine Supply Chains Yeukai Gilmore Magara, a biotech student consultant with DREAM Venture Labs, studied how artificial intelligence can help create smarter, fairer and more resilient vaccine supply chains. His report, “Optimizing Pandemic Vaccine Supply Chains: AI-Driven Strategies & Future Directions,” examines how AI could drastically reduce waste and make vaccines more accessible in future health crises.Read the story in the Katz School blog. Biotech Student Evaluates Gene-Editing Tool Read her review Biotech Student Evaluates Gene-Editing Tool A recent review led by Bibi Ayesa, on how CRISPR-Cas9, a novel gene-editing tool, works was published in the International Journal of Science and Research Archive.Read the story in the Katz School blog. Turning Off Key Protein Makes Mice Infertile Read about the research Turning Off Key Protein Makes Mice Infertile At the Katz School's Graduate Symposium on Science, Technology and Health, Tahereh Ghafoori and Rupali Khane presented compelling research that could bring us closer to understanding male infertility, a condition that affects millions of couples worldwide.Read the story in the Katz School blog. Student Research Paves Way for Gene Therapies Read about their research Student Research Paves Way for Gene Therapies At the Katz School’s Graduate Symposium on Science, Health and Technology, Rutu Jagtap and Andres Romero, both students in the M.S. in Biotechnology Management and Entrepreneurship, presented an ambitious research project with big implications for medicine, molecular biology and even developmental biology.Read the story on the Katz School blog. Student Crafts Market Strategy for Cancer Drug Read about Jenny Maharajan Student Crafts Market Strategy for Cancer Drug At the recent Graduate Symposium of Science, Health and Technology, Jenny Maharjan, a student in the M.S. in Biotechnology Management & Entrepreneurship, tackled one of the most daunting challenges in oncology: how to treat aggressive childhood bone cancer with greater precision and fewer side effects.Read the story in the Katz School blog. AI Dashboard Speeds Rare Disease Diagnosis Read about the dashboard AI Dashboard Speeds Rare Disease Diagnosis Students in the M.S. in Biotechnology Management and Entrepreneurship and M.S. in Artificial Intelligence unveiled at the Katz School’s Graduate Symposium on Science, Technology and Health an ambitious solution to one of the most pressing problems in modern medicine: the lack of a centralized, comprehensive and accessible resource for rare diseases.Read the story in the Katz School blog. Biotech Alum Explores Hydroponic Space Greens Read more about Natania Birnbaum's research Biotech Alum Explores Hydroponic Space Greens Natania Birnbaum, a 2024 graduate of the M.S. in Biotechnology Management and Entrepreneurship, conducted a comprehensive survey of the available literature on duckweed biology, genetics and cultivation methods, as well as an investigation into the major companies in the industry and economic projections for the future of the duckweed market.Read the story in the Katz School blog. International Students Spark Cultural Dialogue Read about the students International Students Spark Cultural Dialogue Three Katz School international students, including one from the biotechnology master's program, volunteered to share their experiences from their country of origin with New York City public school children as part of One to World, a New York City–based global leadership and cultural exchange program.Read the story in the Katz School blog. He Used AI to Explore Vaccine Supply Chains Read Yeukai Magara's report He Used AI to Explore Vaccine Supply Chains Yeukai Gilmore Magara, a biotech student consultant with DREAM Venture Labs, studied how artificial intelligence can help create smarter, fairer and more resilient vaccine supply chains. His report, “Optimizing Pandemic Vaccine Supply Chains: AI-Driven Strategies & Future Directions,” examines how AI could drastically reduce waste and make vaccines more accessible in future health crises.Read the story in the Katz School blog. Biotech Student Evaluates Gene-Editing Tool Read her review Biotech Student Evaluates Gene-Editing Tool A recent review led by Bibi Ayesa, on how CRISPR-Cas9, a novel gene-editing tool, works was published in the International Journal of Science and Research Archive.Read the story in the Katz School blog. Turning Off Key Protein Makes Mice Infertile Read about the research Turning Off Key Protein Makes Mice Infertile At the Katz School's Graduate Symposium on Science, Technology and Health, Tahereh Ghafoori and Rupali Khane presented compelling research that could bring us closer to understanding male infertility, a condition that affects millions of couples worldwide.Read the story in the Katz School blog. Student Research Paves Way for Gene Therapies Read about their research Student Research Paves Way for Gene Therapies At the Katz School’s Graduate Symposium on Science, Health and Technology, Rutu Jagtap and Andres Romero, both students in the M.S. in Biotechnology Management and Entrepreneurship, presented an ambitious research project with big implications for medicine, molecular biology and even developmental biology.Read the story on the Katz School blog. Student Crafts Market Strategy for Cancer Drug Read about Jenny Maharajan Student Crafts Market Strategy for Cancer Drug At the recent Graduate Symposium of Science, Health and Technology, Jenny Maharjan, a student in the M.S. in Biotechnology Management & Entrepreneurship, tackled one of the most daunting challenges in oncology: how to treat aggressive childhood bone cancer with greater precision and fewer side effects.Read the story in the Katz School blog. AI Dashboard Speeds Rare Disease Diagnosis Read about the dashboard AI Dashboard Speeds Rare Disease Diagnosis Students in the M.S. in Biotechnology Management and Entrepreneurship and M.S. in Artificial Intelligence unveiled at the Katz School’s Graduate Symposium on Science, Technology and Health an ambitious solution to one of the most pressing problems in modern medicine: the lack of a centralized, comprehensive and accessible resource for rare diseases.Read the story in the Katz School blog. Biotech Alum Explores Hydroponic Space Greens Read more about Natania Birnbaum's research Biotech Alum Explores Hydroponic Space Greens Natania Birnbaum, a 2024 graduate of the M.S. in Biotechnology Management and Entrepreneurship, conducted a comprehensive survey of the available literature on duckweed biology, genetics and cultivation methods, as well as an investigation into the major companies in the industry and economic projections for the future of the duckweed market.Read the story in the Katz School blog.
